ICD-10-CM G13.2: Systemic atrophy primarily affecting the central nervous system in myxedema

ICD-10-CM Diagnosis Code (2025)

Official Description for G13.2

Systemic atrophy primarily affecting the central nervous system in myxedema

Coding Notes & Guidelines for G13.2

Code First

underlying disease, such as:
hypothyroidism (E03.-)
myxedematous congenital iodine deficiency (E00.1)

Parent Code (Less Specific):

G13 - Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

About ICD-10-CM Code G13.2 (Systemic atrophy primarily affecting the central nervous system in myxedema)

ICD-10-CM code G13.2 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM G13.2 became effective on October 1, 2024.

This page provides detailed information about G13.2 - Systemic atrophy primarily affecting the central nervous system in myxedema. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Systemic atrophy primarily affecting the central nervous system in myxedema.